AB Science SA banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
France FR
Employees
36
IPO date
Apr 21, 2010

AB Science SA is a French biopharmaceutical company that develops medicines aimed at diseases where the immune system, inflammation, or certain cancers play a major role. Its work centers on small-molecule drug candidates, especially mast-cell kinase inhibitors, that are designed to change how a disease progresses rather than just treat symptoms. The company does not sell a broad portfolio of commercial drugs; it focuses on research, clinical testing, and regulatory development of a few lead compounds.

The company makes money primarily by advancing these drug candidates through the development process and, if a product is approved, through future drug sales or licensing agreements. Its main customers are not consumers today but doctors, hospitals, and pharmaceutical partners in the markets where its medicines may eventually be used. Because it is a drug developer, its value depends heavily on clinical data, regulatory decisions, and partnerships that can support later-stage development and commercialization.

What makes AB Science different is its narrow focus on a specific drug mechanism and on hard-to-treat conditions such as inflammatory diseases, neurodegenerative disorders, and certain cancers. That puts it in the high-risk, high-reward part of biotech, where scientific progress and trial results matter more than manufacturing scale or a large sales force. It acts as an originator of drug candidates rather than a traditional drug seller.

AB Science SA Investor Relations

Address
3, avenue George V
Paris, Ile-De-France
France

Business Segments

Drug development

AB Science SA develops and tests small-molecule medicines, especially its lead drug candidates built to act on specific biological targets in cancer, inflammatory diseases, and some nervous system disorders. The company...

Customers and revenue model

Management

Mr. Alain Moussy MBA

Co-Founder, Chairman, President, CEO, MD & Scientific Director

Biography unavailable

Mr. Laurent Guy MBA

Chief Financial Officer

Biography unavailable

Mr. Christian FASSOTTE

Global Chief Medical Officer

Biography unavailable

Mr. Alexis BERNARD

Head of Veterinary Sales

Biography unavailable

Mr. Harshad KULKARNI

Head of Statistics

Biography unavailable

Dr. Albert Ahn D.V.M.

President of USA Operations

Biography unavailable

1 / 6